Yes, this is absolutely required. Whenever the directors or shareholding structure of a licensed company wholesaling proprietary Chinese medicines changes, you must notify the Chinese Medicines Board under the Chinese Medicine Council of Hong Kong in writing within 28 days of the change. You must submit details of the change, including identity documents for the new and former directors/shareholders and changes in shareholding percentages. Although a shareholding change does not necessarily require prior approval, notification after the event is mandatory. The Chinese Medicines Board will assess whether the change affects the company's effective control and management to ensure that it continues to meet the licensing requirements.
HONG KONG DRUG LICENSING
There has been a shareholding change in the company holding my wholesale proprietary Chinese medicine licence. Must this be reported to the Chinese Medicine Council (CMRO)?
A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.
Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.
Back to Category I: Renewals, Changes and Penalties for Breaches (Q401-Q450) Search more questions